🔴 HCW Biologics is trading 11.36% down today as oil and Treasury yields revive inflation fears

HCW Biologics is trading 11.36% down at $1.71, with broader macro risk-off sentiment the clearest available context for the decline.

• Rising oil prices and Treasury yields have revived inflation concerns amid the U.S.-Iran stalemate; Reuters reported global stocks fell Monday.
• No clear company-specific announcement was identified for September 28. The latest company release, dated September 24, announced pricing of a $1.5 million private placement.